Prolongation of GLP-1 Adherence Using Continuous Glucose Monitoring
Excellence Medical and Research (EMR) invites eligible individuals to participate in a groundbreaking clinical study aimed at improving diabetes management through the use of advanced continuous glucose monitoring (CGM) technology.
Study Overview
This study investigates the effectiveness of the FreeStyle Libre 3 Continuous Glucose Monitoring System in helping people with Type 2 diabetes maintain adherence to GLP-1 or GIP/GLP-1 medications. Participants will be randomly assigned to use either the FreeStyle Libre 3 system or their existing standard of care to manage diabetes while starting GLP-1 therapy.
Eligibility Criteria
You may qualify if:
You are 18 years or older.
You have a diagnosis of Type 2 diabetes.
You are starting GLP-1 or GIP/GLP-1 medication for diabetes management.
You are willing to participate in all study visits and follow study instructions.
You cannot participate if:
You have Type 1 diabetes or gestational diabetes.
You are currently using or have previously used GLP-1 or GIP/GLP-1 medications.
You are currently using a Continuous Glucose Monitor (CGM) to manage your diabetes.
You have allergies to medical adhesives or other materials used in the study.
Study Duration
Participants will be involved for approximately 210 days and will have up to three clinic visits at Excellence Medical and Research in Miami Gardens, FL.
Compensation
Eligible participants will receive compensation for their time and travel.
Benefits of Participation
Gain access to innovative glucose monitoring technology.
Contribute to research that may benefit millions of people managing diabetes.
Contact Information
To see if you qualify, please contact us at 786-320-5229 or email us at info@emrclinic.com.
Kommentare